Drug class
Nitroimidazole Antibiotics
Nitroimidazole antibiotics are a class of synthetic antimicrobial agents that include drugs such as metronidazole, tinidazole, and secnidazole. Read more about Nitroimidazole Antibiotics
51 drugs in this class 47 manufacturers
Drugs in Nitroimidazole Antibiotics
METRO IV (metronidazole in sodium chloride)
METRONIDAZOLE
METRONIDAZOLE
METRONIDAZOLE (metronidazole in sodium chloride)
METRONIDAZOLE
TINIDAZOLE
METRONIDAZOLE
METRONIDAZOLE
Nitroimidazole antibiotics are a class of synthetic antimicrobial agents that include drugs such as metronidazole, tinidazole, and secnidazole.
They function as prodrugs that undergo reductive activation within anaerobic microorganisms, generating reactive free radicals that disrupt microbial DNA structure and inhibit nucleic acid synthesis, ultimately causing cell death.
Clinically, they serve as essential therapeutics for treating obligate anaerobic bacterial infections—such as intra-abdominal sepsis, pelvic inflammatory disease, and bacterial vaginosis—as well as parasitic infections, including trichomoniasis, amebiasis, and giardiasis.
-
fda.gov
Nitroimidazole antibiotics are a class of synthetic antimicrobial agents that include drugs such as metronidazole, tinidazole, and secnidazole
-
nih.gov
Nitroimidazole antibiotics are a class of synthetic antimicrobial agents that include drugs such as metronidazole, tinidazole, and secnidazole Clinically, they serve as essential therapeutics for treating obligate anaerobic bacterial infections—such as intra-abdominal sepsis, pelvic inflammatory disease, and bacterial vaginosis—as well as parasitic infections, including trichomoniasis, amebiasis, and giardiasis
-
lecturio.com
Nitroimidazole antibiotics are a class of synthetic antimicrobial agents that include drugs such as metronidazole, tinidazole, and secnidazole They function as prodrugs that undergo reductive activation within anaerobic microorganisms, generating reactive free radicals that disrupt microbial DNA structure and inhibit nucleic acid synthesis, ultimately causing cell death Clinically, they serve as essential therapeutics for treating obligate anaerobic bacterial infections—such as intra-abdominal s...
-
nih.gov
Clinically, they serve as essential therapeutics for treating obligate anaerobic bacterial infections—such as intra-abdominal sepsis, pelvic inflammatory disease, and bacterial vaginosis—as well as parasitic infections, including trichomoniasis, amebiasis, and giardiasis
Sign in to follow this class
Following a drug class requires a free Physicians Office Resource account.